Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 9Sarcoma 4Gynecologic 3Genitourinary 3Other hematologic neoplasm 2Dermatologic 2CNS 2Breast 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Multiple Myeloma 111Neoplasms, Plasma Cell 50Lymphoma, Non-Hodgkin 39Lymphoma 35Hodgkin Disease 35Myelodysplastic Syndromes 32Leukemia, Lymphocytic, Chronic, B-Cell 32Leukemia 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Follicular 29Lymphoma, Mantle-Cell 28Lymphoma, Large-Cell, Immunoblastic 28Burkitt Lymphoma 28Lymphoma, Large B-Cell, Diffuse 27Lymphoma, B-Cell, Marginal Zone 27Leukemia, Myeloid, Acute 23Myeloproliferative Disorders 21Immunoglobulin Light-chain Amyloidosis 18Leukemia, Myeloid, Chronic-Phase 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 15Primary Myelofibrosis 14Leukemia, Myelomonocytic, Chronic 14Congenital Abnormalities 14Blast Crisis 14Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 13Leukemia, Myeloid, Accelerated Phase 13Myelodysplastic-Myeloproliferative Diseases 12Lymphoma, T-Cell, Cutaneous 10Graft vs Host Disease 10

Interventions

Dexamethasone 33Lenalidomide 14pomalidomide 12daratumumab 12Bortezomib 12venetoclax 7Cyclophosphamide 7isatuximab 6Therapeutics 6trametinib 4carfilzomib 4Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3fludarabine 3dabrafenib 3Vemurafenib 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Drug Therapy 3Denosumab 3Ciprofloxacin 3Calcium Dobesilate 3ridaforolimus 2pembrolizumab 2molibresib 2liposomal amphotericin B 2fludarabine phosphate 2cobimetinib 2afuresertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Filgrastim × Plasma cell × Clear all
NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

University of Arkansas

Phase 3 Completed
668 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡